Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umang Swami

Showing results (111-120 of 170) with videos related to

Pageof 17
Sort By:
Urologic Oncology|August 2, 2022
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinomaNishita Tripathi, Yeonjung Jo, Abhishek Tripathi, et al.
JNCI Cancer Spectrum|January 30, 2025
A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancerNickolas Stabellini, Omar M Makram, Harikrishnan Hyma Kunhiraman, et al.
Prostate Cancer and Prostatic Diseases|January 30, 2025
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapyGeorges Gebrael, Nicolas Sayegh, Chadi Hage Chehade, et al.
JAMA Network Open|July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial CancersChadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2024
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trialSoumyajit Roy, Fred Saad, Yilun Sun, et al.
European Urology Oncology|May 12, 2024
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized TherapyVinay Mathew Thomas, Nicolas Sayegh, Beverly Chigarira, et al.
BMC Cancer|April 18, 2024
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trialAdriana M Coletta, Lea Haverbeck Simon, Kelsey Maslana, et al.
JCO Precision Oncology|May 23, 2024
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMIVinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, et al.
Journal of the American College of Radiology : JACR|March 13, 2026
ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma, Christopher Mejias, Rustain L Morgan, et al.
JAMA Network Open|May 2, 2024
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the USVinay Mathew Thomas, Yeonjung Jo, Nishita Tripathi, et al.
Pageof 17

Showing results (111-120 of 170) with videos related to

Sort By:
Pageof 17
Urologic Oncology|August 2, 2022
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinomaNishita Tripathi, Yeonjung Jo, Abhishek Tripathi, et al.
JNCI Cancer Spectrum|January 30, 2025
A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancerNickolas Stabellini, Omar M Makram, Harikrishnan Hyma Kunhiraman, et al.
Prostate Cancer and Prostatic Diseases|January 30, 2025
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapyGeorges Gebrael, Nicolas Sayegh, Chadi Hage Chehade, et al.
JAMA Network Open|July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial CancersChadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2024
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trialSoumyajit Roy, Fred Saad, Yilun Sun, et al.
European Urology Oncology|May 12, 2024
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized TherapyVinay Mathew Thomas, Nicolas Sayegh, Beverly Chigarira, et al.
BMC Cancer|April 18, 2024
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trialAdriana M Coletta, Lea Haverbeck Simon, Kelsey Maslana, et al.
JCO Precision Oncology|May 23, 2024
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMIVinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, et al.
Journal of the American College of Radiology : JACR|March 13, 2026
ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma, Christopher Mejias, Rustain L Morgan, et al.
JAMA Network Open|May 2, 2024
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the USVinay Mathew Thomas, Yeonjung Jo, Nishita Tripathi, et al.
Pageof 17